Related Articles
Glycogen synthase kinase‑3β regulates tumor necrosis factor‑related apoptosis inducing ligand (TRAIL)‑induced apoptosis via the NF‑κB pathway in hepatocellular carcinoma
Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death
Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells
The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis